FFA
URGN icon

Farther Finance Advisors’s UroGen Pharma URGN Stock Holding History

Farther Finance Advisors’s Portfolio URGN Stock Details URGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$455 Sell
24
-232
-91% -$4.65K ﹤0.01% 5290
2025
Q4 		$6K Buy
256
+211
+469% +$4.58K ﹤0.01% 4203
2025
Q3 		$898 Buy
45
+44
+4,400% +$790 ﹤0.01% 4397
2025
Q2 		$14 Hold
1
– – ﹤0.01% 4445
2025
Q1 		$11 Sell
1
-11
-92% -$117 ﹤0.01% 4218
2024
Q4 		$128 Hold
12
– – ﹤0.01% 3747
2024
Q3 		$152 Buy
12
+6
+100% +$89 ﹤0.01% 3707
2024
Q2 		$99 Hold
6
– – ﹤0.01% 3600
2024
Q1 		$85 Hold
6
– – ﹤0.01% 3405
2023
Q4 		$90 Buy
+6
New +$78 ﹤0.01% 3316

Other funds holding URGN

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $51.9B AUM 40.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return
JFG
Jefferies Financial Group New York $8.2B AUM 40.95% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $90.6B AUM 36.98% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return